Buy Soranix 200 MG (Sorafenib) - Mediaid pharmacy

Soranix 200 MG (Sorafenib)

Product Name : Soranix
Generic Name : Sorafenib
Formulation : Tablet
Available Pack Size : 5×6’s
Available Strengths : 200 mg
Registrations : Bangladesh

Message Us on WhatsApp

Product Information

Soranix (Sorafenib) 200mg is a multi-kinase inhibitor used to treat unresectable hepatocellular carcinoma (liver cancer), advanced renal cell carcinoma (kidney cancer), and radioactive iodine-refractory differentiated thyroid carcinoma in adult patients. It works by blocking multiple kinases involved in both tumour cell growth and the formation of new blood vessels that feed the tumour, slowing cancer progression through a dual mechanism. Manufactured for the Bangladesh market and globally supplied by Mediaid Pharmacy with worldwide shipping.

Basic Product Information of Soranix (Sorafenib) 200mg

Brand Name	Soranix (Sorafenib)
Generic Name	Sorafenib INN (as Sorafenib Tosylate)
Drug Class	Multi-Kinase Inhibitor (RAF, VEGFR, PDGFR, and Others)
Available Strengths	200mg
Formulation	Film-Coated Tablet
Pack Size	5×6’s (30 Tablets per Box). At the standard dose of four 200mg tablets daily, one box covers about 7-8 days, so continuous therapy requires multiple boxes.
Primary Indication	Unresectable Hepatocellular Carcinoma, Advanced Renal Cell Carcinoma, Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma
Regulatory Approvals	USFDA Approved (unresectable HCC, advanced RCC, radioactive iodine-refractory DTC). EMA Approved (HCC, RCC, DTC).
Originator Brand	Nexavar by Bayer
Manufacturer	[Manufacturer name to be confirmed], Bangladesh
Global Supplier	Mediaid Pharmacy, Worldwide Shipping Available
Registration	Registered in Bangladesh
Storage Conditions	Store below 30 degrees Celsius. Keep in a dry place away from light and moisture. Keep out of the reach of children.

How Soranix (Sorafenib) Works

Soranix contains Sorafenib, an oral multi-kinase inhibitor that blocks a broad range of intracellular and cell-surface kinases, including CRAF, BRAF and mutant BRAF, KIT, FLT-3, RET, and VEGFR-1, VEGFR-2, and VEGFR-3, and PDGFR-β. These kinases are involved in two processes that tumours depend on: direct cell proliferation signalling and angiogenesis, the formation of new blood vessels that supply the tumour with oxygen and nutrients.

By inhibiting both the RAF/MEK/ERK signalling pathway and VEGFR/PDGFR-driven angiogenesis, Sorafenib works through a dual mechanism: slowing direct tumour cell growth while also limiting the blood supply the tumour needs to survive and spread. This combined action has made Sorafenib a foundational targeted therapy across several difficult-to-treat cancers, including liver, kidney, and thyroid cancer.

Soranix is an oral tablet taken twice daily, and must be taken on an empty stomach, since food, especially high-fat meals, can meaningfully reduce how much of the drug is absorbed.

Indications for Soranix (Sorafenib)

Soranix (Sorafenib) is indicated for the following conditions:

Unresectable Hepatocellular Carcinoma

For adult patients with unresectable (inoperable) liver cancer, where surgical removal is not possible.

Advanced Renal Cell Carcinoma

For adult patients with advanced kidney cancer that has spread beyond the kidney.

Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma

For adult patients with locally recurrent or metastatic, progressive differentiated thyroid carcinoma that no longer responds to radioactive iodine treatment.

Benefits of Soranix (Sorafenib) 200mg

Dual Anti-Tumour Mechanism

Targets both direct tumour cell growth signalling and the blood vessel formation tumours rely on, through a broad multi-kinase inhibition profile.

Established Across Three Cancer Types

A foundational, long-established targeted therapy for liver, kidney, and radioactive iodine-refractory thyroid cancer.

Oral, Chemotherapy-Free Option

Taken as a tablet rather than by infusion, offering a targeted therapy option that avoids intravenous chemotherapy visits.

Affordable Alternative to Nexavar

Soranix contains the same active ingredient as Nexavar by Bayer, at a significantly lower cost, improving access to this targeted therapy.

Flexible Dose Modification

Uses simple 200mg tablet-based dose steps, allowing straightforward dose reduction if toxicity requires it.

WHO-GMP and cGMP Certified

Manufactured under strict WHO-GMP, cGMP, and ISO-certified standards, ensuring every batch of Soranix meets consistent quality, safety, and efficacy requirements.

How to Take Soranix (Sorafenib)

Route: Oral, taken by mouth

Standard dose: 400mg (two 200mg tablets) taken twice daily, for a total of four tablets (800mg) per day, continued until the patient is no longer benefiting or until unacceptable toxicity occurs.

Without food: Take at least 1 hour before or 2 hours after a meal. Taking Soranix with a high-fat meal can significantly reduce absorption.

Swallowing: Swallow tablets whole with a full glass of water.

Dose reduction for toxicity: If a dose reduction is needed for adverse reactions, the dose is typically reduced first to 400mg once daily, and if further reduction is needed, to a single 400mg dose every other day, as directed by the treating physician.

Before surgery: Soranix should be stopped at least 10 days before any scheduled surgery, due to its effect on wound healing, and only resumed once the surgical wound is adequately healed, as determined by your surgeon.

Missed dose: If a dose is missed, do not take it if it is close to the time of the next scheduled dose; skip the missed dose and resume the normal schedule. Do not double the dose.

Paediatric use: Safety and efficacy have not been established in patients under 18 years of age.

Prescription Medication. Soranix should only be initiated and monitored by an oncologist or specialist physician experienced in managing liver, kidney, or thyroid cancer. Blood pressure, cardiac status, and liver function require regular monitoring, particularly in the first weeks of treatment. Always follow your prescribing physician’s exact instructions.

Monitoring and Dosage Adjustments

Regular monitoring is essential during Soranix treatment. Your healthcare provider will monitor blood pressure regularly, especially during the first 6 weeks of treatment, as well as liver function, signs of bleeding, and cardiac status, given reported risks of cardiac ischaemia and QT interval prolongation. Monitoring also includes watchfulness for hand-foot skin reaction (redness, pain, or blistering of the palms and soles) and other skin changes, and assessment for abdominal pain that could indicate gastrointestinal perforation. Report any chest pain, severe skin reaction, unusual bleeding, or severe abdominal pain to your doctor immediately.

Drug Interactions and Important Information

Sorafenib is metabolised primarily through CYP3A4 and UGT1A9. Avoid strong CYP3A4 inducers such as rifampin, carbamazepine, phenytoin, and St. John’s Wort, as these can significantly reduce Sorafenib levels and efficacy. Concomitant neomycin may also reduce Sorafenib absorption and should generally be avoided.

Sorafenib may increase exposure to other medications metabolised through similar pathways, including doxorubicin, irinotecan, and docetaxel, when co-administered. Patients taking warfarin should have their INR monitored regularly, as changes in clotting parameters and bleeding events have been reported. Always inform your physician of all medications, supplements, and herbal products you are currently taking before starting Soranix.

Side Effects and Precautions

Common Side Effects

Hand-foot skin reaction and rash

Diarrhoea

Fatigue

Alopecia (hair thinning)

Hypertension

Decreased appetite and weight loss

Nausea and abdominal pain

Serious Warnings and Precautions

Cardiac ischaemia and myocardial infarction.

Haemorrhage, including severe or fatal bleeding events.

Gastrointestinal perforation. Report severe abdominal pain immediately.

QT interval prolongation.

Hepatotoxicity, including drug-induced liver injury.

Impaired wound healing. Interrupt treatment before planned surgery.

Not recommended during pregnancy; embryo-fetal toxicity.

Who Should Use Soranix (Sorafenib)?

Soranix is suitable for adult patients diagnosed with unresectable hepatocellular carcinoma, advanced renal cell carcinoma, or radioactive iodine-refractory differentiated thyroid carcinoma. It is prescribed by oncologists and specialist physicians experienced in managing these cancers. A thorough baseline assessment including blood pressure, liver function, and cardiac status is required before starting treatment.

Manufacturer

Soranix (Sorafenib) is manufactured in Bangladesh under strict WHO-GMP, cGMP, and ISO-certified standards, offering an affordable and bioequivalent alternative to Nexavar by Bayer at a fraction of the cost. [Please confirm the exact manufacturer name so it can be added here and in the specs table above.]

Global Supplier: Mediaid Pharmacy with Worldwide Shipping

Mediaid Pharmacy is a trusted global supplier of specialty oncology medications. We ensure Soranix (Sorafenib) is accessible to patients and healthcare providers worldwide through reliable worldwide shipping. Whether you are located in South Asia, the Middle East, Africa, Europe, or beyond, Mediaid Pharmacy provides fast and reliable delivery with full order support. Contact us directly via WhatsApp, phone, or WeChat for pricing, availability, and delivery enquiries.

Why Choose Soranix (Sorafenib) from Mediaid Pharmacy?

Soranix represents a foundational targeted therapy option for patients with liver, kidney, or radioactive iodine-refractory thyroid cancer. As the generic equivalent of Nexavar by Bayer, it delivers the same active ingredient, Sorafenib, with the same proven multi-kinase inhibition mechanism at a dramatically more affordable price. Manufactured under WHO-GMP and cGMP standards and distributed globally by Mediaid Pharmacy, Soranix gives patients worldwide access to high-quality targeted oncology therapy without the financial burden of brand-name alternatives. For patients and physicians seeking a proven, affordable, and accessible Sorafenib option with worldwide delivery, Soranix from Mediaid Pharmacy is the trusted choice.

Frequently Asked Questions About Soranix (Sorafenib)

What is Soranix (Sorafenib) used for?

Soranix (Sorafenib) is a multi-kinase inhibitor used to treat unresectable hepatocellular carcinoma (liver cancer), advanced renal cell carcinoma (kidney cancer), and radioactive iodine-refractory differentiated thyroid carcinoma in adults. It works by blocking kinases involved in both tumour growth and the tumour’s blood supply.

How should I take Soranix (Sorafenib)?

Soranix is taken as two 200mg tablets (400mg) twice daily, for four tablets a day in total, on an empty stomach — at least 1 hour before or 2 hours after a meal. Always follow your prescribing physician’s exact instructions, as taking Soranix with food, especially a high-fat meal, can reduce how much of the drug your body absorbs.

What strength and pack size is Soranix available in?

Soranix is available as a 200mg tablet, supplied as 5×6’s (30 tablets per box). Since the standard dose is four tablets per day, one box covers roughly a week to 10 days; patients should plan to order enough boxes for continuous, uninterrupted therapy.

Is Soranix the same as Nexavar (Sorafenib by Bayer)?

Yes. Soranix is the generic equivalent of Nexavar. Both contain the same active ingredient, Sorafenib, in the same dosage form and strength. Soranix delivers the same clinical benefits as Nexavar at a significantly lower cost, making it a more accessible option for patients worldwide.

What are the side effects of Soranix (Sorafenib)?

Common side effects include hand-foot skin reaction, diarrhoea, fatigue, hair thinning, and hypertension. Serious but less common risks include cardiac ischaemia, significant bleeding, gastrointestinal perforation, and liver toxicity. Regular monitoring of blood pressure, liver function, and skin condition is required throughout treatment. Always consult your physician for a complete assessment of your individual risks and benefits.

Do I need to stop Soranix before surgery?

Yes. Soranix affects wound healing, so treatment should be stopped at least 10 days before any planned surgery and only restarted once your surgeon confirms the wound has healed adequately. Always tell any surgeon or dentist that you are taking Soranix before a procedure.

Can I order Soranix (Sorafenib) online with worldwide shipping?

Yes. Mediaid Pharmacy supplies Soranix (Sorafenib) 200mg globally with worldwide shipping. Contact us via WhatsApp, phone, or WeChat at +8801773428128 or email us at info@mediaidpharmacy.com to enquire about pricing, availability, and delivery to your country.

Order Soranix (Sorafenib) 200mg with Worldwide Shipping

Phone / WhatsApp / WeChat: +8801773428128 | Email: info@mediaidpharmacy.com

Message on WhatsApp